Ricolinostat: Additional Phase I/II data

Data from 43 patients with relapsed or refractory MM in the Phase Ib portion of an open-label, dose-escalation, U.S. Phase I/II trial showed that oral ricolinostat plus Velcade bortezomib and dexamet...